Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

BUY
$20.69 - $20.91 $298,267 - $301,438
14,416 Added 1.54%
951,369 $19.9 Million
Q2 2022

Aug 02, 2022

BUY
$13.8 - $20.82 $4.57 Million - $6.9 Million
331,352 Added 54.71%
936,953 $19.4 Million
Q1 2022

May 11, 2022

BUY
$15.96 - $18.87 $283,832 - $335,584
17,784 Added 3.03%
605,601 $10.2 Million
Q4 2021

Feb 08, 2022

SELL
$16.79 - $20.37 $252,370 - $306,181
-15,031 Reduced 2.49%
587,817 $11.7 Million
Q3 2021

Nov 09, 2021

SELL
$18.14 - $27.03 $1.39 Million - $2.07 Million
-76,764 Reduced 11.3%
602,848 $10.9 Million
Q2 2021

Aug 12, 2021

SELL
$25.24 - $30.86 $499,146 - $610,287
-19,776 Reduced 2.83%
679,612 $18.4 Million
Q1 2021

May 11, 2021

BUY
$28.29 - $39.89 $7.88 Million - $11.1 Million
278,391 Added 66.13%
699,388 $21 Million
Q4 2020

Feb 05, 2021

BUY
$24.45 - $31.59 $10.3 Million - $13.3 Million
420,997 New
420,997 $12.1 Million

Others Institutions Holding CVET

About COVETRUS, INC.


  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.